We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.04B
AUM Growth
+$449M
Cap. Flow
+$66.9M
Cap. Flow %
0.95%
Top 10 Hldgs %
69.19%
Holding
135
New
6
Increased
54
Reduced
51
Closed
9

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$37.6M
2
MDLZ icon
Mondelez International
MDLZ
+$11.6M
3
NKE icon
Nike
NKE
+$11.2M
4
CL icon
Colgate-Palmolive
CL
+$10.4M
5
CNC icon
Centene
CNC
+$9.46M

Sector Composition

Rank Sector Weight
1 Financials 27.87%
2 Healthcare 18.82%
3 Consumer Discretionary 16.92%
4 Communication Services 15.48%
5 Materials 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWPH
76
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.23M 0.05%
31,863
+4,765
+18% +$510K
CHRS icon
77
Coherus Oncology
CHRS
$217M
$3.19M 0.05%
238,971
-2,534
-1% -$33.5K
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.08M 0.04%
183,235
+1,087
+0.6% +$17.7K
ACHC icon
79
Acadia Healthcare
ACHC
$2.56B
$3.02M 0.04%
63,305
+9,305
+17% +$454K
PBYI icon
80
Puma Biotechnology
PBYI
$397M
$2.85M 0.04%
23,792
-16,042
-40% -$1.49M
SUPN icon
81
Supernus Pharmaceuticals
SUPN
$2.72B
$2.85M 0.04%
71,143
-527
-0.7% -$22.8K
DXCM icon
82
DexCom
DXCM
$29.1B
$2.78M 0.04%
227,340
-17,040
-7% -$301K
BHC icon
83
Bausch Health
BHC
$1.68B
$2.78M 0.04%
193,908
-3,102
-2% -$46.9K
NEO icon
84
NeoGenomics
NEO
$2.02B
$2.72M 0.04%
244,300
-1,700
-0.7% -$16.5K
TSRO
85
DELISTED
TESARO, Inc.
TSRO
$2.7M 0.04%
20,916
-25,816
-55% -$3.2M
HIND
86
Vyome Holdings
HIND
$14.4M
0
TD icon
87
Toronto Dominion Bank
TD
$195B
$2.62M 0.04%
37,332
ACRS icon
88
Aclaris Therapeutics
ACRS
$708M
$2.49M 0.04%
96,300
-300
-0.3% -$8.04K
SNA icon
89
Snap-on
SNA
$21.4B
$2.31M 0.03%
15,507
+2,830
+22% +$425K
AQN icon
90
Algonquin Power & Utilities
AQN
$4.66B
$2.21M 0.03%
167,900
-96,100
-36% -$1.02M
ELGX
91
DELISTED
Endologix Inc
ELGX
$2.2M 0.03%
49,333
-768
-2% -$35K
AFAM
92
DELISTED
Almost Family Inc
AFAM
$2.05M 0.03%
38,200
+14,200
+59% +$724K
OTEX icon
93
Open Text
OTEX
$6.23B
$1.96M 0.03%
48,700
+19,300
+66% +$625K
FSTX
94
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.87M 0.03%
27,800
+21,519
+343% +$1.23M
CVS icon
95
CVS Health
CVS
$137B
$1.83M 0.03%
22,470
STML
96
DELISTED
Stemline Therapeutics, Inc.
STML
$1.78M 0.03%
+160,000
New +$1.5M
MA icon
97
Mastercard
MA
$502B
$1.74M 0.02%
12,300
-7,519
-38% -$995K
INGR icon
98
Ingredion
INGR
$6.45B
$1.65M 0.02%
13,700
HRTX icon
99
Heron Therapeutics
HRTX
$92.5M
$1.61M 0.02%
+100,000
New +$1.57M
ZVRA icon
100
Zevra Therapeutics
ZVRA
$578M
$1.61M 0.02%
27,221
+3,365
+14% +$179K

Similar funds

C WorldWide Group's Q3 2017 Portfolio in Review

As of Q3 2017, C WorldWide Group held 135 positions worth $7.04B, up 6.8% from $6.59B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

C WorldWide Group's Q3 2017 filing shows 6 new, 54 increased, 51 reduced and 9 closed positions. Its largest new stake was Zimmer Biomet: 61,428 shares worth $6.98M. The largest sale was Home Depot, an estimated $37.6M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • C WorldWide Group's largest Q3 2017 buy was Zimmer Biomet: 61,428 shares worth $6.98M.
  • C WorldWide Group added most to Citigroup in Q3 2017, an estimated $52.2M increase.
  • C WorldWide Group's biggest Q3 2017 reduction was Home Depot, cutting an estimated $37.6M.
  • C WorldWide Group fully exited Nike in Q3 2017, selling an estimated $11.2M.
  • C WorldWide Group's ten largest holdings make up 69% of its $7.04B portfolio in Q3 2017.
  • C WorldWide Group opened 6 new positions and closed 9 in Q3 2017.
  • C WorldWide Group's portfolio value rose 6.8% quarter-over-quarter to $7.04B.

Based on C WorldWide Group's 13F filing for Q3 2017, filed 6 Nov 2017.